SCHEMBL25357478

SCHEMBL25357478

N[C@@H](Cc1ccc(OCCNC(=O)C2CCN(CC(=O)O)CC2)cc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.48
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ PKM P14618 1/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ ITGB3 P05106 1/20 0.47
▸ ITGA2B P08514 1/20 0.47
▸ LTA4H P09960 4/20 0.45
▸ LMNA P02545 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HTR2A P28223 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HRH2 P25021 1/20 0.41
▸ HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25357494 1.00 HRH3 (0.48) HRH3MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL26014843 0.85 KMT2A (0.56) HRH3MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL25360874 0.84 ITGB3 (0.49) ITGB3ITGA2BLTA4HHTR2AHRH2
SCHEMBL26009739 0.84 ITGB3 (0.49) ITGB3ITGA2BLTA4HHTR2AHRH2
SCHEMBL31688659 0.84 ITGB3 (0.49) ITGB3ITGA2BLTA4HHTR2AHRH2
Bromide SCHEMBL31074002 0.83 ITGB3 (0.48) ITGB3ITGA2BLTA4HHTR2AHRH2
SCHEMBL26008260 0.77 ITGB3 (0.48) HRH3ITGB3ITGA2BLTA4HHTR2A
SCHEMBL25357508 0.77 ITGB3 (0.46) MEN1KMT2ASMN1; SMN2ITGB3ITGA2B
SCHEMBL19157853 0.76 ITGB3 (0.52) SMN1; SMN2ITGB3ITGA2BLTA4HLMNA
SCHEMBL21644790 0.75 ITGB3 (0.63) RAB9ASMN1; SMN2NPC1PKMITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP HRH3 3074/4885MEN1 1901/4885KMT2A 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback